CMRX Research and Charts

CMRX - Chimerix Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-05 (Delayed quote data 2025-01-06)

Last 3.54	Change ⇓ -0.08 (-2.21%)	Volume 1,914,924
	Open 3.71	High 3.80	Low 3.51

8EMA (Daily) 3.38	40EMA (Daily) 2.27	50EMA (Daily) 2.08	STO (Daily) 82.044	MACD Hist (Daily) 0.027
8EMA (Weekly) 2.683	40EMA (Weekly) 1.47	50EMA (Weekly) 1.41	STO (Weekly) 90.228	MACD Hist (Weekly) 0.622


Company Profile
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through license agreements and a federal contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) for research and advanced development of drugs to treat various human diseases. The company operates only in one business segment namely pharmaceuticals.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.